meglumine and Osteosarcoma

meglumine has been researched along with Osteosarcoma in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bloem, JL; Hogendoorn, PC; Nooy, MA; Taminiau, AH; van der Woude, HJ; Verstraete, KL	1
Sundaram, M	1
Chantraine, JM; Dresse, MF; Gillet, P; Hoyoux, C; Marguglio, A; Thiry, A	1
Fairclough, DL; Fletcher, BD; Gronemeyer, SA; Hanna, SL	1
Charpentier, A; de Baere, T; di Paola, M; Shapeero, LG; Terrier, P; Vanel, D	1

Trials

1 trial(s) available for meglumine and Osteosarcoma

Article	Year
Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery. AJR. American journal of roentgenology, 1995, Volume: 165, Issue:3 Topics: Adolescent; Adult; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Male; Meglumine; Neoplasm, Residual; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Sarcoma, Ewing	1995

Article

Year

Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.

AJR. American journal of roentgenology, 1995, Volume: 165, Issue:3

Topics: Adolescent; Adult; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Male; Meglumine; Neoplasm, Residual; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Sarcoma, Ewing

1995

Other Studies

4 other study(ies) available for meglumine and Osteosarcoma

Article	Year
The use of gadolinium in the MR imaging of bone tumors. Seminars in ultrasound, CT, and MR, 1997, Volume: 18, Issue:4 Topics: Antineoplastic Agents; Bone Neoplasms; Contrast Media; Drug Combinations; Edema; Evaluation Studies as Topic; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Joint Diseases; Magnetic Resonance Imaging; Meglumine; Muscle, Skeletal; Muscular Diseases; Necrosis; Neoplasm Staging; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Sarcoma; Sensitivity and Specificity; Treatment Outcome	1997
[Chronic visceral leishmaniasis during chemotherapy for metastatic osteosarcoma]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1998, Volume: 5, Issue:3 Topics: Amphotericin B; Antifungal Agents; Antimony; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Child; Chronic Disease; Humans; Interferon-gamma; Leishmaniasis, Visceral; Liposomes; Lung Neoplasms; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Osteosarcoma; Recurrence; Spinal Neoplasms	1998
Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy. Radiology, 1992, Volume: 184, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Sarcoma, Synovial; Soft Tissue Neoplasms	1992
Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging. Radiology, 1992, Volume: 185, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Contrast Media; Doxorubicin; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Methotrexate; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Remission Induction; Subtraction Technique	1992